Bluejay Diagnostics, Inc. Shareholders' Equity
Bluejay Diagnostics, Inc. (BJDX) had Shareholders' Equity of $9.41 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $9.41M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $4.18M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $5.98M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $3.69M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $9.41M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $4.18M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $5.98M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $3.69M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $5.29M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $3.87M 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $5.73M 10-Q · filed 2026-08-12 | |
| 2024-09-30 | $7.16M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $8.64M 10-Q · filed 2025-11-07 | |
| 2024-03-31 | $3.37M 10-Q · filed 2025-11-07 | |
| 2023-12-31 | $2.89M 10-K · filed 2026-03-06 | |
| 2023-09-30 | $5.21M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $6.38M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $9.16M 10-Q · filed 2024-11-07 | $9.16M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $11.54M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $13.81M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $16.66M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $18.49M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $20.38M 10-K · filed 2024-03-28 | |
| 2021-09-30 | -$1.08M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $123.48K 10-Q · filed 2022-11-09 | -$123.48K 10-Q · filed 2021-12-16 |
| 2021-03-31 | -$4.30M 10-Q · filed 2022-11-09 | -$4.30M 10-Q · filed 2021-12-16 |
| 2020-12-31 | -$4.21M 10-K · filed 2023-03-20 | |
| 2020-09-30 | -$3.74M 10-Q · filed 2021-12-16 | |
| 2020-06-30 | -$3.55M 10-Q · filed 2021-12-16 | |
| 2020-03-31 | -$3.31M 10-Q · filed 2021-12-16 | |
| 2019-12-31 | -$2.93M 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |